Director, Deal Advisory
+41 58 249 58 16
Swap, don’t sell: Driving value through asset swaps
The Swiss Pharmaceuticals sector produced four USD1 billion+ deals in the first half of 2018. This is not surprising given the efforts by Pharmaceuticals and Life Sciences businesses to push new boundaries and continuously innovate.
Brexit and Switzerland: 10 employment & immigration considerations
Basel-Stadt votes yes to tax reform and remains tax-attractive
Das Rennen um die Technologieführerschaft
Intelligent Automation: revolutionizing how insurers do business